continues its new launches
Recession did bring a
slowdown on Shimadzu Analytical’s overall
life sciences business, this however did not stop Shimadzu
Analytical India from launching five new products, upgrading its
technologies and continuing its R&D projects.
Shimadzu Analytical (India), a
subsidiary of Shimadzu Asia Pacific (based out of Japan), has a
business focus on offering technologies in the field of
analytical, scientific instrumentation, process control instrumentation
and environmental monitoring. Started in 2006 in India, the company
caters to a number of industrial segments, with a chunk of business
coming from the life sciences industry. For its
operations in India, Shimadzu has four marketing
partners namely Spinco Biotech, Toshvin Analytical, Swan
Environmental and Amkette Analytics. Shimadzu Analytical has
been operating in the Indian life sciences space for the past 40 years
through these distributors.
The company in India clocked an annual sales revenue of Rs 154 crore
from life sciences alone as against Rs 128 crore in fiscal 2007-08.
Apart from life sciences, the company also caters to other industry
segments like automobiles. A break up of their total
revenue shows that around 70 percent of their revenue comes
from life sciences alone, while the remaining 30 percent comes from
Commenting on the slowdown in growth, Senya Imamichi, managing
director, Shimadzu Analytical India, said, “Last year we were
expecting a growth of 15-17 percent, but due to the sudden economic
crisis and recession worldwide, there was a slowdown in our growth.
However, there might have been slowdown but we did not see any negative
growth in our business in India.”
Since most of Shimadzu’s business transactions happens in the
Japanese Yen, the company saw a status quo in their turnover due to
forex fluctuations. In India, many customers postponed or put a freeze
on their projects which did show its repercussions. “During
recession in India. most of the life sciences companies postponed or
freezed their projects in the last six months. The demand was
definitely there but they are careful in investing in big
projects. This also includes Shimadzu‘s customer
projects, especially those who wanted to expand their
business,” elaborated Imamichi.
However this did not stop the company from launching five
products into the Indian market. In the area of life science,
the company moves forward with the comprehensive development of
instruments, reagents, and contract analysis. This development is based
mainly on protein analysis technology, which is important for medical
treatment and developing pharmaceuticals, and mass DNA sequencing
technology, which is important for genetic analysis.
“Despite recession we still continue and would go
ahead with our product launches even for this year,”